Delivery Order SPE2DB20D1004-SPE2DB25FNJZA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,260.98 to AmerisourceBergen Drug Corp for Eohilia 2 mg/10 ml stick pack pharmaceutical supplies on August 11, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and calls for delivery to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 12, 2025. The delivery order is executed under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $14,411.01 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Eohilia 2 mg/10 mL stick pack units. This firm fixed-price delivery order, with an ultimate completion date of July 31, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside...
- The Defense Logistics Agency awarded a $13,537.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for EOHILIA 2 mg/10 ml stick pack pharmaceutical products. The contract, awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, carries no set-aside designation and was competitively awarded. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,275.60 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Eohilia 2 mg/10 ml stick pack units. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. Performance is scheduled for completion by August 20, 2025, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $3,782.94 to AmerisourceBergen Drug Corp for Eohilia 2 mg/10 ml stick pack pharmaceutical product on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The contract carries no...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,420.67 by the Defense Logistics Agency for the supply of Eohilia 2 mg/10 ml stick pack medication. The contract, executed on July 18, 2025, with an ultimate completion date of July 21, 2025, was issued on a firm fixed-price basis with no set-aside designation, indicating competitive award. Performance will be completed at the awardee's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $4,673.47 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Eohilia 2 mg/10 ml stick pack medication. The contract represents a firm fixed-price delivery order with a completion date of July 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation applied. This delivery order is issued under AmerisourceBergen...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $10,298.10 firm fixed-price delivery order is for the supply of EOHILIA 2 MG/10 ML STICK PACK 10ML pharmaceutical products. The contract has an ultimate completion date of May 20, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,260.98, is for the delivery of medical products including the pharmaceutical item "EOHILIA 2 MG/10 ML STICK PACK 10ML." The contract is a firm fixed-price arrangement without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,268.36 firm fixed price delivery order is for the supply of a medical product described as "EOHILIA 2 MG/10 ML STICK PACK 10ML". The contract has an ultimate completion date of December 30, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB25FNJZADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,260.98 to AmerisourceBergen Drug Corp for Eohilia 2 mg/10 ml stick pack pharmaceutical product, with an ultimate completion date of August 11, 2025. This competitive delivery order, utilizing firm fixed pricing, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to the prime contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Through its comprehensive IDC vehicle, the company supplies an extensive portfolio of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. This delivery order exemplifies the company's role in fulfilling routine pharmaceutical supply needs under its broader agreement with the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/8/25 |